[57214] Suspicion of a hostile takeover attempt of the state-owned insulin manufacturer 'Indar' in Ukraine
[57214] Suspicion of a hostile takeover attempt of the state-owned insulin manufacturer 'Indar' in Ukraine
Reports in Ukraine reveal suspicions of moves toward a private takeover of the state-owned pharmaceutical company Indar, against the backdrop of a sharp decline in the company's market share and profitability.
Crisis at the state-owned pharmaceutical company 'Indar'
Media outlets in Ukraine are reporting a suspicion of "raiding" (hostile takeover) of the state-owned insulin manufacturer Indar, which is at the center of a public storm. According to reports on the Telegram channels Труха⚡️Україна and Україна Online, the company's market share has plummeted to just 6%, while its profits have been cut by three times. Furthermore, it is alleged that the price of insulin produced in Ukraine is currently more expensive than analogues imported from Germany and Poland.
In a joint report by Труха⚡️Україна and Україна⚡️Новини⚡️Війна, a worrying picture emerges regarding the management's conduct: the CEO, Lyubov Vishnevskaya, has been serving in her position since 2012, despite her contract ending in 2015, and there are claims that she owns private businesses in the same field, which raises concerns of a severe conflict of interest.
At the center of the affair is the private investment company 'Luraq Investment', which already holds about 29% of the factory's shares. According to the sources, the company is now trying to purchase the state's stake in the factory through legal proceedings and without a tender. The UA Stream channel notes that 2025 data indicates continued erosion, with the market share of Ukrainian manufacturers in the entire sector dropping from 58% in 2019 to just 18%.
There are growing concerns among media outlets that the strategic asset is being "intentionally led to bankruptcy" to facilitate its transfer to private hands, all while the government maintains silence on the issue.